Back to results
US 12,037,379 B2Granted
CD71 binding fibronectin type III domains
AssigneeARO Biotherapeutics Company
InventorsRussell C. Addis, Zhanna Druzina, Robert V. Kolakowski, Steven G. Nadler, Karyn T. O'Neil, Yao Xin
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to polypeptides, such as fibronectin type III (FN3) domains that can bind CD71, their conjugates, isolated nucleotides encoding the molecules, vectors, host-cells, as well as methods of making and using the same.
Claims20
A polypeptide comprising the amino acid sequence of SEQ ID NO:
- 209.
Dependencies are inferred from the claim text.